Cargando…

Predicting biochemical-recurrence-free survival using a three-metabolic-gene risk score model in prostate cancer patients

BACKGROUND: Biochemical recurrence (BCR) after initial treatment, such as radical prostatectomy, is the most frequently adopted prognostic factor for patients who suffer from prostate cancer (PCa). In this study, we aimed to construct a prognostic model consisting of gene expression profiles to pred...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yiqiao, Tao, Zijia, Li, Lei, Zheng, Jianyi, Chen, Xiaonan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896158/ https://www.ncbi.nlm.nih.gov/pubmed/35246070 http://dx.doi.org/10.1186/s12885-022-09331-8

Ejemplares similares

A Three-Metabolic-Genes Risk Score Model Predicts Overall Survival in Clear Cell Renal Cell Carcinoma Patients
por: Zhao, Yiqiao, et al.
Publicado: (2020)

A united risk model of 11 immune‑related gene pairs and clinical stage for prediction of overall survival in clear cell renal cell carcinoma patients
por: Tao, Zijia, et al.
Publicado: (2021)

Nomograms for predicting overall and cancer-specific survival of patients with chromophobe renal cell carcinoma after nephrectomy: a retrospective SEER-based study
por: Zheng, Jianyi, et al.
Publicado: (2022)

Identification of a three-m6A related gene risk score model as a potential prognostic biomarker in clear cell renal cell carcinoma
por: Zhao, Yiqiao, et al.
Publicado: (2020)

Prognostic Characteristics and Immune Effects of N(6)-Methyladenosine and 5-Methylcytosine-Related Regulatory Factors in Clear Cell Renal Cell Carcinoma
por: Li, Lei, et al.
Publicado: (2022)

5-methylcytosine RNA methyltransferases and their potential roles in cancer
por: Li, Mingyang, et al.
Publicado: (2022)

Coffee consumption and risk of prostate cancer: a systematic review and meta-analysis
por: Chen, Xiaonan, et al.
Publicado: (2021)

Role of methyltransferase-like enzyme 3 and methyltransferase-like enzyme 14 in urological cancers
por: Tao, Zijia, et al.
Publicado: (2020)

Identification of the miRNA-mRNA regulatory pathways and a miR-21-5p based nomogram model in clear cell renal cell carcinoma
por: Zhao, Yiqiao, et al.
Publicado: (2020)

Construction of DNA methylation-based nomogram for predicting biochemical-recurrence-free survival in prostate cancer
por: Zhu, Jiayu, et al.
Publicado: (2022)

Gene signatures predict biochemical recurrence‐free survival in primary prostate cancer patients after radical therapy
por: Su, Qiang, et al.
Publicado: (2021)

A Glycolysis-Related Five-Gene Signature Predicts Biochemical Recurrence-Free Survival in Patients With Prostate Adenocarcinoma
por: Xu, Zijun, et al.
Publicado: (2021)

FASN Protein Overexpression Indicates Poor Biochemical Recurrence-Free Survival in Prostate Cancer
por: Cao, Zhi, et al.
Publicado: (2020)

Combined overexpression of HIVEP3 and SOX9 predicts unfavorable biochemical recurrence-free survival in patients with prostate cancer
por: Qin, Guo-qiang, et al.
Publicado: (2014)

Prediction of Biochemical Recurrence-Free Survival of Prostate Cancer Patients Leveraging Multiple Gene Expression Profiles in Tumor Microenvironment
por: Zhou, Rui, et al.
Publicado: (2021)

Reduced Connexin 43 expression is associated with tumor malignant behaviors and biochemical recurrence-free survival of prostate cancer
por: Xu, Ning, et al.
Publicado: (2016)

Aberrant Methylation of PCDH10 Predicts Worse Biochemical Recurrence-Free Survival in Patients with Prostate Cancer After Radical Prostatectomy
por: Wang, Li, et al.
Publicado: (2014)

Biochemical recurrence-free survival and pathological outcomes after radical prostatectomy for high-risk prostate cancer
por: Beauval, Jean-Baptiste, et al.
Publicado: (2016)

Preoperative Predictors of Biochemical Recurrence-Free Survival in High-Risk Prostate Cancer Following Radical Prostatectomy
por: Nkengurutse, Gerard, et al.
Publicado: (2020)

Conditional biochemical recurrence-free survival after radical prostatectomy in patients with high-risk prostate cancer
por: Park, Sung-Woo, et al.
Publicado: (2020)

Preoperative PROSTATE scoring system: a potential predictive tool for the risk of biochemical recurrence after radical prostatectomy
por: Zhang, Zhe-Nan, et al.
Publicado: (2018)

A Novel Gene Signature-Based Model Predicts Biochemical Recurrence-Free Survival in Prostate Cancer Patients after Radical Prostatectomy
por: Shi, Run, et al.
Publicado: (2019)

Identification of a DNA Repair Gene Signature and Establishment of a Prognostic Nomogram Predicting Biochemical-Recurrence-Free Survival of Prostate Cancer
por: Long, Gongwei, et al.
Publicado: (2021)

Positive expression of NR6A1/CT150 as a predictor of biochemical recurrence-free survival in prostate cancer patients
por: Cheng, Gong, et al.
Publicado: (2016)

Association of doublecortin-like kinase 1 with tumor aggressiveness and poor biochemical recurrence-free survival in prostate cancer
por: Jiang, Donggen, et al.
Publicado: (2018)

Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer
por: von Eyben, Rie, et al.
Publicado: (2023)

Identification of genes that predict the biochemical recurrence of prostate cancer
por: Chu, Jianfeng, et al.
Publicado: (2018)

Predicting biochemical recurrence of prostate cancer with artificial intelligence
por: Pinckaers, Hans, et al.
Publicado: (2022)

A Novel Ferroptosis-Based Molecular Signature Associated with Biochemical Recurrence-Free Survival and Tumor Immune Microenvironment of Prostate Cancer
por: Ke, Zhi-Bin, et al.
Publicado: (2022)

The Prognostic Factors of Biochemical Recurrence-Free Survival Following Radical Prostatectomy
por: Chalieopanyarwong, Virote, et al.
Publicado: (2017)

Pathological outcomes and biochemical recurrence-free survival after radical prostatectomy for high-risk prostate cancer in the Indian population
por: Bijalwan, Priyank, et al.
Publicado: (2018)

Risk prediction models for biochemical recurrence after radical prostatectomy using prostate-specific antigen and Gleason score
por: Hu, Xin-Hai, et al.
Publicado: (2014)

Genetic risk score to predict biochemical recurrence after radical prostatectomy in prostate cancer: prospective cohort study
por: Oh, Jong Jin, et al.
Publicado: (2017)

Identification and validation of an E2F-related gene signature for predicting recurrence-free survival in human prostate cancer
por: Yang, Cheng, et al.
Publicado: (2022)

Prostate-specific antigen nadir within 1 year of radiotherapy combined with hormone therapy predicts cancer-specific mortality and biochemical recurrence-free survival in prostate cancer patients
por: Cetin, Ilknur Alsan, et al.
Publicado: (2022)

The Impact of Prostate Cancer Upgrading and Upstaging on Biochemical Recurrence and Cancer-Specific Survival
por: Bakavičius, Arnas, et al.
Publicado: (2020)

Predictive Value of the Cancer of the Prostate Risk Assessment Score for Recurrence-Free Survival After Radical Prostatectomy in Korea: A Single-Surgeon Series
por: Seo, Won Ik, et al.
Publicado: (2014)

Identification of Potential Predictor of Biochemical Recurrence in Prostate Cancer
por: Wei, Jingchao, et al.
Publicado: (2022)

Predicting Biochemical Disease-Free Survival after Prostate Stereotactic Body Radiotherapy: Risk-Stratification and Patterns of Failure
por: Katz, Alan, et al.
Publicado: (2016)

Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma
por: Liu, Xi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c1gabcpq8488r1rk96rj7p628h